Market overview
The global colorimetric fructosamine assay kit market is worth USD 57 mn in 2026 and is forecast to reach USD 92 mn by 2036, growing at a 4.8% CAGR. China is the largest country market and Clinical chemistry reagents is the largest by product segment.
| Scope | Test reagents that measure fructosamine, a marker of average blood sugar over two to three weeks, by colorimetric assay: clinical chemistry reagents, point-of-care strips and research kits. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 55 mn |
| Value 2026 | USD 57 mn |
| Value 2036 | USD 92 mn |
| CAGR 2026-2036 | 4.8% |
| Volume 2026 | 18.7 million tests |
| Volume 2036 | 28.5 million tests |
| Average price 2026 | USD 3.07 per test |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Colorimetric Fructosamine Assay Kit market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 57 mn |
| 2027 | USD 60 mn |
| 2028 | USD 63 mn |
| 2029 | USD 66 mn |
| 2030 | USD 69 mn |
| 2031 | USD 73 mn |
| 2032 | USD 76 mn |
| 2033 | USD 80 mn |
| 2034 | USD 84 mn |
| 2035 | USD 88 mn |
| 2036 | USD 92 mn |
Colorimetric Fructosamine Assay Kit market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Clinical chemistry reagents | 62.0% | 57.6% | USD 36 mn | 4.0% |
| Research assay kits | 26.0% | 24.9% | USD 15 mn | 4.3% |
| Point-of-care tests | 12.0% | 17.5% | USD 6.9 mn | 8.8% |
By end user
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospital laboratories | 44.0% | 41.1% | USD 25 mn | 4.1% |
| Reference laboratories | 30.0% | 30.8% | USD 17 mn | 5.1% |
| Diabetes clinics and research | 26.0% | 28.0% | USD 15 mn | 5.6% |
By detection principle
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Nitroblue tetrazolium reduction | 52.0% | 48.0% | USD 30 mn | 4.0% |
| Enzymatic colorimetric | 30.0% | 32.0% | USD 17 mn | 5.5% |
| Rate and kinetic assays | 18.0% | 20.0% | USD 10 mn | 5.9% |
By format
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Reagent kits | 56.0% | 52.0% | USD 32 mn | 4.0% |
| Microplate kits | 28.0% | 28.0% | USD 16 mn | 4.8% |
| Automated analyzer packs | 16.0% | 20.0% | USD 9.2 mn | 7.2% |
By sample
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Serum | 56.0% | 53.0% | USD 32 mn | 4.2% |
| Plasma | 28.0% | 29.0% | USD 16 mn | 5.2% |
| Whole blood | 16.0% | 18.0% | USD 9.2 mn | 6.0% |
Top 25 countries for colorimetric fructosamine assay kit by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 80.0% of 2026 revenue and the 25 countries below together hold 94.8%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | China | USD 11 mn | 20.0% | USD 21 mn | 6.4% |
| 2 | United States | USD 10 mn | 18.0% | USD 16 mn | 4.5% |
| 3 | Japan | USD 6.9 mn | 12.0% | USD 9.2 mn | 2.9% |
| 4 | Germany | USD 4.0 mn | 7.0% | USD 5.6 mn | 3.4% |
| 5 | India | USD 3.5 mn | 6.0% | USD 7.1 mn | 7.5% |
| 6 | Brazil | USD 2.3 mn | 4.0% | USD 3.9 mn | 5.3% |
| 7 | France | USD 2.3 mn | 4.0% | USD 3.2 mn | 3.4% |
| 8 | Italy | USD 1.7 mn | 3.0% | USD 2.3 mn | 2.9% |
| 9 | United Kingdom | USD 1.7 mn | 3.0% | USD 2.6 mn | 4.1% |
| 10 | Turkey | USD 1.7 mn | 3.0% | USD 2.9 mn | 5.5% |
| 11 | Russia | USD 1.1 mn | 1.9% | USD 1.8 mn | 5.0% |
| 12 | Mexico | USD 1.1 mn | 1.8% | USD 1.7 mn | 5.0% |
| 13 | Spain | USD 0.89 mn | 1.6% | USD 1.3 mn | 3.8% |
| 14 | Canada | USD 0.75 mn | 1.3% | USD 1.1 mn | 3.8% |
| 15 | Australia | USD 0.72 mn | 1.2% | USD 1.1 mn | 3.8% |
| 16 | Netherlands | USD 0.71 mn | 1.2% | USD 1.0 mn | 3.8% |
| 17 | Egypt | USD 0.62 mn | 1.1% | USD 1.0 mn | 5.1% |
| 18 | Saudi Arabia | USD 0.55 mn | 0.9% | USD 0.90 mn | 5.1% |
| 19 | Argentina | USD 0.48 mn | 0.8% | USD 0.79 mn | 5.0% |
| 20 | Poland | USD 0.36 mn | 0.6% | USD 0.60 mn | 5.1% |
| 21 | Thailand | USD 0.29 mn | 0.5% | USD 0.48 mn | 5.0% |
| 22 | Indonesia | USD 0.27 mn | 0.5% | USD 0.44 mn | 5.0% |
| 23 | Taiwan | USD 0.26 mn | 0.5% | USD 0.42 mn | 5.0% |
| 24 | Belgium | USD 0.25 mn | 0.4% | USD 0.37 mn | 3.8% |
| 25 | South Korea | USD 0.19 mn | 0.3% | USD 0.31 mn | 5.1% |
| Rest of world | USD 3.0 mn | 5.2% | USD 4.4 mn | 4.0% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Roche Diagnostics
- Randox
- Sekisui Diagnostics
- Beckman Coulter
- Siemens Healthineers
Group 2: Regional and specialist players
- Diazyme Laboratories
- Fujifilm Wako
- Spinreact
- Biolabo
- Kamiya Biomedical
- Sentinel Diagnostics
Group 3: Emerging and niche players
- Cayman Chemical
- BioAssay Systems
- Elabscience
- Abcam
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the colorimetric fructosamine assay kit market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 4.8% is calculated from the resulting values.
The market is divided by product, by end user, by detection principle, by format, by sample. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the colorimetric fructosamine assay kit market?
The global colorimetric fructosamine assay kit market is estimated at USD 55 mn in 2025 and USD 57 mn in 2026.
How fast will the colorimetric fructosamine assay kit market grow?
It is forecast to reach USD 92 mn by 2036, a compound annual growth rate of 4.8% from 2026, an increase of USD 34 mn.
Which country is the largest market for colorimetric fructosamine assay kit?
China is the largest market by revenue at USD 11 mn in 2026, 20.0% of the global total. The three largest countries together hold 50.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 7.5% a year from 2026 to 2036.
Which colorimetric fructosamine assay kit segment is largest?
In the by product split, Clinical chemistry reagents is the largest segment with 62.0% of 2026 revenue.
Who are the leading colorimetric fructosamine assay kit companies?
Global leaders include Roche Diagnostics, Randox, Sekisui Diagnostics, Beckman Coulter.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- At-Home Syphilis TestingUSD 58 mn · 24.0% CAGR
- Blood Bag Tube SealerUSD 58 mn · 4.5% CAGR
- Digital Colony CounterUSD 59 mn · 5.5% CAGR
- AI Aortic Surgery Planning ToolUSD 55 mn · 13.0% CAGR
- Amyotrophic Lateral Sclerosis Gene TestingUSD 62 mn · 10.5% CAGR
- Respiration Monitor BeltUSD 63 mn · 5.2% CAGR
- AI Capsule Endoscopy Reading PlatformUSD 64 mn · 17.0% CAGR
- Touch Activated Phlebotomy DevicesUSD 72 mn · 18.0% CAGR